TherapeuticsMD (TXMD) EBITDA Margin (2009 - 2026)
TherapeuticsMD's EBITDA Margin came in at -82.97% for Q2 2026, down 20.05 percentage points from -62.92% a year earlier but up 3.91 percentage points from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TherapeuticsMD reported EBITDA Margin of -109.20%, up 22.68 percentage points year-over-year; for FY2025, it was -132.56%, up 185.61 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +97.04 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -318.17% in FY2024 (+265.62 pp), -583.79% in FY2023 (-587.20 pp), 3.41% in FY2022 (+3067.57 pp) and -3064.17% in FY2021 (-2834.56 pp).
- The five-year range for quarterly EBITDA Margin is -4188.22% (Q2 2022) to 71.10% (Q4 2022).
- Year-over-year, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +537.61 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2023 (a gain of 3652.06 percentage points), and the weakest in Q2 2022 (a drop of 4039.80 percentage points).
- Business Quant data shows TXMD's EBITDA Margin at -86.88% (Q1 2026), -162.93% (Q4 2025) and -97.70% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - | -82.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -82.97% |
| Mar 31, 2026 | -86.88% |
| Dec 31, 2025 | -162.93% |
| Sep 30, 2025 | -97.70% |
| Jun 30, 2025 | -62.92% |
| Mar 31, 2025 | -301.78% |
| Dec 31, 2024 | -82.76% |
| Sep 30, 2024 | -189.76% |
| Jun 30, 2024 | -1,114.96% |
| Mar 31, 2024 | -322.36% |
| Dec 31, 2023 | -194.02% |
| Sep 30, 2023 | -3,100.00% |
| Jun 30, 2023 | -536.16% |
| Mar 31, 2023 | -634.62% |
| Dec 31, 2022 | 71.10% |
| Sep 30, 2022 | -4,024.29% |
| Jun 30, 2022 | -4,188.22% |
| Mar 31, 2022 | -2,524.60% |
| Dec 31, 2021 | -202.09% |
| Sep 30, 2021 | -153.08% |
API Access
TherapeuticsMD EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();